Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Parainfluenza Virus 2”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableStudy completedNCT01302418
What this trial is testing

Collection and Testing of Respiratory Samples

Who this might be right for
QIAGEN ResPlex II Advanced PanelInfluenza ARespiratory Syncytial Virus Infections+15 more
QIAGEN Gaithersburg, Inc 272
Early research (Phase 1)Study completedNCT01021397
What this trial is testing

Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children

Who this might be right for
Paramyxoviridae InfectionsVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 12
Not applicableLooking for participantsNCT05864118
What this trial is testing

Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses

Who this might be right for
Respiratory Tract Infections
University of Nebraska 1,000
Early research (Phase 1)Study completedNCT01254175
What this trial is testing

Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children

Who this might be right for
Parainfluenza Virus 3, Human
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT06026514
What this trial is testing

Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults

Who this might be right for
SARS-CoV-2 Infection
National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Ended earlyNCT04933968
What this trial is testing

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Who this might be right for
Respiratory Tract Viral InfectionsHuman Metapneumovirus (hMPV) InfectionParainfluenza (PIV) Infection+2 more
AlloVir 17
Early research (Phase 1)Looking for participantsNCT06546423
What this trial is testing

Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vaccines Expressing the Fusion Glycoprotein of HMPV Delivered by Nasal Spray to HPIV3-Seropositive Children 24 to <60 Months of Age

Who this might be right for
Human MetapneumovirusHuman Parainfluenza Virus Type 3
National Institute of Allergy and Infectious Diseases (NIAID) 25
Early research (Phase 1)Study completedNCT01139437
What this trial is testing

Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants

Who this might be right for
Human Parainfluenza Virus 2
National Institute of Allergy and Infectious Diseases (NIAID) 45
Testing effectiveness (Phase 2)Looking for participantsNCT06999603
What this trial is testing

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

Who this might be right for
Viral Pneumonia
Synairgen Research Ltd. 550
Early research (Phase 1)Study completedNCT00308412
What this trial is testing

Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants

Who this might be right for
Paramyxoviridae InfectionsVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 45